Lyme Disease: Laboratory Issues

Infectious Disease Clinics of North America

Volumn 22, Issue 2, 2008, Pages 301-313

  Aguero Rosenfeld, Maria E ^a,b  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b WESTCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; C PEPTIDE; C6 PEPTIDE; NUCLEIC ACID;

ANTIBODY DETECTION; ANTIGEN DETECTION; BACTERIUM CULTURE; BLOOD CULTURE; BLOOD SAMPLING; BORRELIA BURGDORFERI; CEREBROSPINAL FLUID ANALYSIS; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA CHRONICUM MIGRANS; HUMAN; IMMUNOASSAY; LABORATORY DIAGNOSIS; LYME DISEASE; MICROSCOPY; NONHUMAN; NUCLEIC ACID ANALYSIS; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; REVIEW; SERODIAGNOSIS; SEROLOGY; SKIN; SYNOVIAL FLUID; TWO TIER TESTING; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BORRELIA BURGDORFERI; DNA, BACTERIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNODOMINANT EPITOPES; LYME DISEASE; POLYMERASE CHAIN REACTION; SKIN; SYNOVIAL FLUID;

EID: 42949178417     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idc.2007.12.005     Document Type: Review

References (80)

1. Aguero-Rosenfeld M.E., Wang G., Schwartz I., et al. Diagnosis of Lyme borreliosis. Clin Microbiol Rev 18 (2005) 484-509
2. van Dam A.P., Kuiper H., Vos K., et al. Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin Infect Dis 17 (1993) 708-717
3. de Koning J., Bosma R.B., and Hoogskamp-Korstanje J.A.A. Demonstration of spirochetes in patients with Lyme disease with a modified silver stain. J Med Microbiol 23 (1987) 261-267
4. Coyle P.K., Deng Z., Schutzer S.E., et al. Detection of Borrelia burgdorferi antigens in cerebrospinal fluid. Neurology 43 (1993) 1093-1098
5. Coyle P.K., Schutzer S.E., Belman A.L., et al. Cerebrospinal fluid immune complexes in patients exposed to Borrelia burgdorferi: detection of Borrelia-specific and -nonspecific complexes. Ann Neurol 28 (1990) 739-744
6. Klempner M.S., Schmid C.H., Hu L., et al. Intralaboratory reliability of serologic and urine testing for Lyme disease. Am J Med 110 (2001) 217-219
7. Brettschneider S., Bruckbauer H., Klugbauer N., et al. Diagnostic value of PCR for detection of Borrelia burgdorferi in skin biopsy and urine samples from patients with skin borreliosis. J Clin Microbiol 36 (1998) 2658-2665
8. Rijpkema S.G., Tazelaar D.J., Molkenboer M., et al. Detection of Borrelia afzelii, Borrelia burgdorferi sensu stricto, Borrelia garinii, and group VS116 by PCR in skin biopsies of patients with erythema migrans and acrodermitis chronica atrophicans. Clin Microbiol Infect 3 (1997) 109-116
9. Schwartz I., Wormser G.P., Schwartz J.J., et al. Diagnosis of early Lyme disease by polymerase chain reaction amplification and culture of skin biopsies from erythema migrans lesions. J Clin Microbiol 30 (1992) 3082-3088
10. Steere A.C., Sikand V.K., Meurice F., et al. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. N Engl J Med 339 (1998) 209-215
11. Goodman J.L., Bradley J.F., Ross A.E., et al. Bloodstream invasion in early Lyme disease: results from a prospective, controlled, blinded study using the polymerase chain reaction. Am J Med 99 (1995) 6-12
12. Nocton J.J., Bloom B.J., Rutledge B.J., et al. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in cerebrospinal fluid in Lyme neuroborreliosis. J Infect Dis 174 (1996) 623-627
13. Lebech A.M., Hansen K., Brandrup F., et al. Diagnostic value of PCR for detection of Borrelia burgdorferi DNA in clinical specimens from patients with erythema migrans and Lyme neuroborreliosis. Mol Diagn 5 (2000) 139-150
14. Nocton J.J., Dressler F., Rutledge B.J., et al. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N Engl J Med 330 (1994) 229-234
15. Dumler J.S. Molecular diagnosis of Lyme disease: review and meta-analysis. Mol Diagn 6 (2001) 1-11
16. Burgdorfer W., Barbour A.G., Hayes S.F., et al. Lyme disease-a tick-borne spirochetosis?. Science 216 (1982) 1317-1319
17. Kelly R. Cultivation of Borrelia hermsii. Science 173 (1971) 443-444
18. Barbour A.G. Isolation and cultivation of Lyme disease spirochetes. Yale J Biol Med 57 (1984) 521-525
19. Preac-Mursic V., Wilske B., and Schierz G. European Borrelia burgdorferi isolated from humans and ticks-culture conditions and antibiotic susceptibility. Zentralbl Bakteriol Mikrobiol Hyg [A] 263 (1986) 112-118
20. Pollack R.J., Telford III S.R., and Spielman A. Standardization of medium for culturing Lyme disease spirochetes. J Clin Microbiol 31 (1993) 1251-1255
21. Nadelman R.B., Nowakowski J., Forseter G., et al. The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans. Am J Med 100 (1996) 502-508
22. Stanek G., Klein J., Bittner R., et al. Isolation of Borrelia burgdorferi from the myocardium of a patient with longstanding cardiomyopathy. N Engl J Med 322 (1990) 249-252
23. Wormser G.P., Bittker S., Cooper D., et al. Comparison of the yields of blood cultures using serum or plasma from patients with early Lyme disease. J Clin Microbiol 38 (2000) 1648-1650
24. Reed K.D. Laboratory testing for Lyme disease: possibilities and practicalities. J Clin Microbiol 40 (2002) 319-324
25. Berger B.W., Johnson R.C., Kodner C., et al. Cultivation of Borrelia burgdorferi from erythema migrans lesions and perilesional skin. J Clin Microbiol 30 (1992) 359-361
26. Jurca T., Ruzic-Sabljic E., Lotric-Furlan S., et al. Comparison of peripheral and central biopsy sites for the isolation of Borrelia burgdorferi sensu lato from erythema migrans skin lesions. Clin Infect Dis 27 (1998) 636-638
27. Nadelman R.B., Nowakowski J., Forseter G., et al. Failure to isolate Borrelia burgdorferi after antimicrobial therapy in culture-documented Lyme borreliosis associated with erythema migrans: report of a prospective study. Am J Med 94 (1993) 583-588
28. Wormser G.P., Bittker S., Cooper D., et al. Yield of large-volume blood cultures in patients with early Lyme disease. J Infect Dis 184 (2001) 1070-1072
29. Marques A.R., Stock F., and Gill V. Evaluation of a new culture medium for Borrelia burgdorferi. J Clin Microbiol 38 (2000) 4239-4241
30. Nadelman R.B., Pavia C.S., Magnarelli L.A., et al. Isolation of Borrelia burgdorferi from the blood of seven patients with Lyme disease. Am J Med 88 (1990) 21-26
31. Cimperman J., Maraspin V., Lotric-Furlan S., et al. Lyme meningitis: a one-year follow up controlled study. Wien Klin Wochenschr 111 (1999) 961-963
32. Karlsson M., Hovind-Hougen K., Svenungsson B., et al. Cultivation and characterization of spirochetes from cerebrospinal fluid of patients with Lyme borreliosis. J Clin Microbiol 28 (1990) 473-479
33. Strle F., Ruzic-Sabljic E., Cimperman J., et al. Comparison of findings for patients with Borrelia garinii and Borrelia afzelii isolated from cerebrospinal fluid. Clin Infect Dis 43 (2006) 704-710
34. Schmidli J., Hunziker T., Moesli P., et al. Cultivation of Borrelia burgdorferi from joint fluid three months after treatment of facial palsy due to Lyme borreliosis. [letter]. J Infect Dis 158 (1988) 905-906
35. Mitchell P.D., Reed K.D., Aspeslet T.L., et al. Comparison of four immunoserologic assays for detection of antibodies to Borrelia burgdorferi in patients with culture-positive erythema migrans. J Clin Microbiol 32 (1994) 1958-1962
36. Aguero-Rosenfeld M.E., Nowakowski J., Bittker S., et al. Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J Clin Microbiol 34 (1996) 1-9
37. Fraser C.M., Casjens S., Huang W.M., et al. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 390 (1997) 580-586
38. de Silva A.M., and Fikrig E. Borrelia burgdorferi genes selectively expressed in ticks and mammals. Parasitol Today 13 (1997) 267-270
39. Schwan T.G., and Piesman J. Temporal changes in outer surface proteins A and C of the Lyme disease-associated spirochete, Borrelia burgdorferi, during the chain of infection in ticks and mice. J Clin Microbiol 38 (2000) 382-388
40. Crother T.R., Champion C.I., Wu X.Y., et al. Antigenic composition of Borrelia burgdorferi during infection of SCID mice. Infect Immun 71 (2003) 3419-3428
41. Fikrig E., Feng W., Barthold S.W., et al. Arthropod- and host-specific Borrelia burgdorferi bbk32 expression and the inhibition of spirochete transmission. J Immunol 164 (2000) 5344-5351
42. Hubner A., Yang X., Nolen D.M., et al. Expression of Borrelia burgdorferi OspC and DbpA is controlled by a RpoN-RpoS regulatory pathway. Proc Natl Acad Sci U S A 98 (2001) 12724-12729
43. Miller J.C., von Lackum K., Babb K., et al. Temporal analysis of Borrelia burgdorferi Erp protein expression throughout the mammal-tick infectious cycle. Infect Immun 71 (2003) 6943-6952
44. Ohnishi J., Piesman J., and de Silva A.M. Antigenic and genetic heterogeneity of Borrelia burgdorferi populations transmitted by ticks. Proc Natl Acad Sci U S A 98 (2001) 670-675
45. Nowalk A.J., Gilmore R.D., and Carroll J.A. Serologic proteome analysis of Borrelia burgdorferi membrane-associated proteins. Infect Immun 74 (2006) 3864-3873
46. Craft J.E., Fischer D.K., Shimamoto G.T., et al. Antigens of Borrelia burgdorferi recognized during Lyme disease. Appearance of a new immunoglobulin M response and expansion of the immunoglobulin G response late in the illness. J Clin Invest 78 (1986) 934-939
47. Aguero-Rosenfeld M.E., Nowakowski J., McKenna D.F., et al. Serodiagnosis in early Lyme disease. J Clin Microbiol 31 (1993) 3090-3095
48. Dressler F., Whalen J.A., Reinhardt B.N., et al. Western blotting in the serodiagnosis of Lyme disease. J Infect Dis 167 (1993) 392-400
49. Hansen K., Hindersson P., and Pedersen N.S. Measurement of antibodies to the Borrelia burgdorferi flagellum improves serodiagnosis in Lyme disease. J Clin Microbiol 26 (1988) 338-346
50. Johnson B.J., Robbins K.E., Bailey R.E., et al. Serodiagnosis of Lyme disease: accuracy of a two-step approach using a flagella-based ELISA and immunoblotting. J Infect Dis 174 (1996) 346-353
51. Lin T.M., Schubert C.M., Shih F.F., et al. Use of flagellin-enriched antigens in a rapid, simple, and specific quantitative enzyme immunoassay for Lyme disease antibodies in human serum samples. J Immunoassay 12 (1991) 325-346
52. Bruckbauer H.R., Preac-Mursic V., Fuchs R., et al. Cross-reactive proteins of Borrelia burgdorferi. Eur J Clin Microbiol Infect Dis 11 (1992) 224-232
53. Fawcett P.T., Gibney K.M., Rose C.D., et al. Frequency and specificity of antibodies that cross-react with Borrelia burgdorferi antigens. J Rheumatol 19 (1992) 582-587
54. Luft B.J., Dunn J.J., Dattwyler R.J., et al. Cross-reactive antigenic domains of the flagellin protein of Borrelia burgdorferi. Res Microbiol 144 (1993) 251-257
55. Rasiah C., Schiltz E., Reichert J., et al. Purification and characterization of a tryptic peptide of Borrelia burgdorferi flagellin, which reduces cross-reactivity in immunoblots and ELISA. J Gen Microbiol 138 Pt 1 (1992) 147-154
56. Coleman J.L., and Benach J.L. Isolation of antigenic components from the Lyme disease spirochete: their role in early diagnosis. J Infect Dis 155 (1987) 756-765
57. Lagal V., Postic D., Ruzic-Sabljic E., et al. Genetic diversity among Borrelia strains determined by single-strand conformation polymorphism analysis of the OspC gene and its association with invasiveness. J Clin Microbiol 41 (2003) 5059-5065
58. Masuzawa T., Kurita T., Kawabata H., et al. Relationship between infectivity and OspC expression in Lyme disease Borrelia. FEMS Microbiol Lett 123 (1994) 319-324
59. Seinost G., Dykhuizen D.E., and Dattwyler R.J. Four clones of Borrelia burgdorferi sensu stricto cause invasive infection in humans. Infect Immun 67 (1999) 3518-3524
60. Mathiesen M.J., Holm A., Christiansen M., et al. The dominant epitope of Borrelia garinii outer surface protein C recognized by sera from patients with neuroborreliosis has a surface-exposed conserved structural motif. Infect Immun 66 (1998) 4073-4079
61. Simpson W.J., Schrumpf M.E., and Schwan T.G. Reactivity of human Lyme borreliosis sera with a 39-kilodalton antigen specific to Borrelia burgdorferi. J Clin Microbiol 28 (1990) 1329-1337
62. Ramamoorthy R., Povinelli L., and Philipp M.T. Molecular characterization, genomic arrangement, and expression of bmpD, a new member of the bmp class of genes encoding membrane proteins of Borrelia burgdorferi. Infect Immun 64 (1996) 1259-1264
63. Zhang J.R., Hardham J.M., Barbour A.G., et al. Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes. Cell 89 (1997) 275-285
64. Lawrenz M.B., Hardham J.M., Owens R.T., et al. Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi. J Clin Microbiol 37 (1999) 3997-4004
65. Sadziene A., Jonsson M., Bergstrom S., et al. A bactericidal antibody to Borrelia burgdorferi is directed against a variable region of the OspB protein. Infect Immun 62 (1994) 2037-2045
66. Carroll J.A., El Hague N., Miller J.C., et al. Borrelia burgdorferi RevA antigen is a surface-exposed outer membrane protein whose expression is regulated in response to environmental temperature and pH. Infect Immun 69 (2001) 5286-5293
67. Callister S.M., Jobe D.A., Schell R.F., et al. Sensitivity and specificity of the borreliacidal-antibody test during early Lyme disease: a 'gold standard'?. Clin Diagn Lab Immunol 3 (1996) 399-402
68. Aguero-Rosenfeld M.E. Detection of Borrelia burgdorferi antibodies. In: Isenberg H.D. (Ed). Clinical microbiology procedures handbook. 2nd edition (2004), ASM Press, Washington (DC) p. 11.6.1-10
69. Engstrom S.M., Shoop E., and Johnson R.C. Immunoblot interpretation criteria for serodiagnosis of early Lyme disease. J Clin Microbiol 33 (1995) 419-427
70. Centers for Disease Control and Prevention. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep 44 (1995) 590-591
71. Bacon R.M., Biggerstaff B.J., Schriefer M.E., et al. Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates. J Infect Dis 187 (2003) 1187-1199
72. Nowakowski J., Schwartz I., Liveris D., et al. Laboratory diagnostic techniques for patients with early Lyme disease associated with erythema migrans: a comparison of different techniques. Clin Infect Dis 33 (2001) 2023-2027
73. Wilske B., Fingerle V., and Schulte-Spechtel U. Microbiological and serological diagnosis of Lyme borreliosis. FEMS Immunol Med Microbiol 49 (2007) 13-21
74. Magnarelli L.A., Lawrenz M., Norris S.J., et al. Comparative reactivity of human sera to recombinant VlsE and other Borrelia burgdorferi antigens in class-specific enzyme-linked immunosorbent assays for Lyme borreliosis. J Med Microbiol 51 (2002) 649-655
75. Liang F.T., Alvarez A.L., Gu Y.J., et al. An immunodominant conserved region within the variable domain of VlsE, the variable surface antigen of Borrelia burgdorferi. J Immunol 163 (1999) 5566-5573
76. Marangoni A., Sparacino M., and Cavrini F. Comparative evaluation of three different ELISA methods for the diagnosis of early culture-confirmed Lyme disease in Italy. J Med Microbiol 54 (2005) 361-367
77. Liang F.T., Steere A.C., Marques A.R., et al. Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE. J Clin Microbiol 37 (1999) 3990-3996
78. Nyman D., Willen L., Jansson C., et al. VlsE C6 peptide and IgG ELISA antibody analysis for clinical diagnosis of Lyme borreliosis in an endemic area. Clin Microbiol Infect 12 (2006) 496-497
79. Centers for Disease Control and Prevention. Notice to readers: caution regarding testing for Lyme disease. MMWR 54 (2005) 125
80. Feder H.M., Johnson B.J.B., O'Connell S., et al. A critical appraisal of "chronic Lyme disease". N Engl J Med 357 (2007) 1422-1431